News Focus
News Focus
icon url

tstanley1968

06/27/11 1:01 PM

#520 RE: SozoStocks #519

Never said I disliked Regenicin.

They are in debt, have no revenue and don't even have the right to market PermaDerm.

At a more realistic price the upside potential is huge if they have any success with the FDA trial, but to big a risk at .22